BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Clinical Outcome
25 results:

  • 1. Accumulation of copy number alterations and clinical progression across advanced prostate cancer.
    Grist E; Friedrich S; Brawley C; Mendes L; Parry M; Ali A; Haran A; Hoyle A; Gilson C; Lall S; Zakka L; Bautista C; Landless A; Nowakowska K; Wingate A; Wetterskog D; Hasan AMM; Akato NB; Richmond M; Ishaq S; Matthews N; Hamid AA; Sweeney CJ; Sydes MR; Berney DM; Lise S; ; Parmar MKB; Clarke NW; James ND; Cremaschi P; Brown LC; Attard G
    Genome Med; 2022 Sep; 14(1):102. PubMed ID: 36059000
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Loss of KLK4::KLKP1 pseudogene expression by RNA chromogenic in-situ hybridization is associated with PTEN loss and increased risk of biochemical recurrence in a cohort of middle eastern men with prostate cancer.
    Bakker A; Slack JC; Palanisamy N; Carskadon S; Ghosh S; Khalifeh I; Bismar TA
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3721-3728. PubMed ID: 35982181
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. outcome of primary androgen deprivation therapy in super-elderly men with localized high-risk prostate cancer.
    Yamamoto Y; Akashi Y; Kiba K; Hirayama A; Uemura H
    Anticancer Drugs; 2022 Jul; 33(6):534-538. PubMed ID: 35276692
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [clinical STUDY OF OPEN RADICAL CYSTECTOMY AND ILEAL CONDUIT CONSTRUCTION FOR BLADDER cancer: RESULTS OF 15-YEAR SINGLE CENTER EXPERIENCE].
    Uemura T; Ishibashi T; Pae S; Shirakawa N; Somoto T; Shinohara M; Kobayashi M; Komaru A; Fukasawa S
    Nihon Hinyokika Gakkai Zasshi; 2021; 112(2):89-95. PubMed ID: 35444087
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Negative Predictive Value of prostate Multiparametric Magnetic Resonance Imaging among Men with Negative prostate Biopsy and Elevated prostate Specific Antigen: A clinical outcome Retrospective Cohort Study.
    Lo G; Burton KR; Haider MA; Fleshner N; Finelli A; Ghai S
    J Urol; 2019 Dec; 202(6):1159-1165. PubMed ID: 31188731
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Health Technology Assessment of Carbon-ion Beam Radiotherapy: A Systematic Review of clinical Effectiveness and Safety for 54 Oncological Indications in 12 Tumour Regions.
    Goetz G; Mitic M; Mittermayr T; Wild C
    Anticancer Res; 2019 Apr; 39(4):1635-1650. PubMed ID: 30952702
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Predictive efficacy of the 2014 International Society of Urological Pathology Gleason grading system in initially diagnosed metastatic prostate cancer.
    Sun GX; Shen PF; Zhang XM; Gong J; Gui HJ; Shu KP; Liu JD; Zhao J; Yang YJ; Chen XQ; Chen N; Zeng H
    Asian J Androl; 2017; 19(5):573-578. PubMed ID: 27569001
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Phase I trial outcomes in older patients with advanced solid tumours.
    Khan KH; Yap TA; Ring A; Molife LR; Bodla S; Thomas K; Zivi A; Smith A; Judson I; Banerji U; de Bono JS; Kaye SB
    Br J Cancer; 2016 Feb; 114(3):262-8. PubMed ID: 26757260
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Adenocarcinoma of the prostate with Gleason pattern 5 on core biopsy: frequency of diagnosis, morphologic subpatterns, and relation to pattern distribution based on the modified Gleason grading system.
    Shah RB; Tadros Y
    Hum Pathol; 2014 Nov; 45(11):2263-9. PubMed ID: 25228336
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. DOC-2/DAB2 interacting protein status in high-risk prostate cancer correlates with outcome for patients treated with radiation therapy.
    Jacobs C; Tumati V; Kapur P; Yan J; Hong D; Bhuiyan M; Xie XJ; Pistenmaa D; Yu L; Hsieh JT; Saha D; Kim DW
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):729-35. PubMed ID: 24867541
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Protocol-based image-guided salvage brachytherapy. Early results in patients with local failure of prostate cancer after radiation therapy.
    Lahmer G; Lotter M; Kreppner S; Fietkau R; Strnad V
    Strahlenther Onkol; 2013 Aug; 189(8):668-74. PubMed ID: 23824103
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system.
    Dong F; Wang C; Farris AB; Wu S; Lee H; Olumi AF; McDougal WS; Young RH; Wu CL
    Am J Surg Pathol; 2012 Jun; 36(6):838-43. PubMed ID: 22592143
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Selective lymph node dissection for castration-resistant prostate cancer.
    Busch J; Hinz S; Kempkensteffen C; Erber B; Klopf C; Weikert S; Miller K; Magheli A
    Urol Int; 2012; 88(4):441-6. PubMed ID: 22398510
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Two decades' experience with a prospective biobank for urologic oncology: research, clinical care, and the patients' view.
    Huber J; Herpel E; Jakobi H; Hadaschik BA; Pahernik S; Hohenfellner M
    Urol Oncol; 2013 Oct; 31(7):990-6. PubMed ID: 22386623
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Analysis of surgical treatment and effect of spinal metastatic tumors].
    Ye SM; Qi XS; Mao ZX; Wang QM; Wei XC
    Zhongguo Gu Shang; 2011 Dec; 24(12):977-81. PubMed ID: 22276502
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy.
    Goldner G; Dimopoulos J; Kirisits C; Pötter R
    Strahlenther Onkol; 2009 Jul; 185(7):438-45. PubMed ID: 19714305
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Potential for higher treatment failure in obese patients: correlation of elevated body mass index and increased daily prostate deviations from the radiation beam isocenters in an analysis of 1,465 computed tomographic images.
    Wong JR; Gao Z; Merrick S; Wilson P; Uematsu M; Woo K; Cheng CW
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):49-55. PubMed ID: 19084352
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
    Nobes JP; Khaksar SJ; Hawkins MA; Cunningham MJ; Langley SE; Laing RW
    Radiother Oncol; 2008 Jul; 88(1):121-6. PubMed ID: 18499289
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us?
    Zapatero A; Mínguez R; Nieto S; Martín de Vidales C; García-Vicente F
    Eur Urol; 2009 Apr; 55(4):902-9. PubMed ID: 18485578
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. clinical outcome of Taiwanese men with metastatic prostate cancer compared with other ethnic groups.
    Chen CH; Tzai TS; Huang SP; Wu HC; Tai HC; Chang YH; Pu YS
    Urology; 2008 Dec; 72(6):1287-92. PubMed ID: 18372020
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.